Bimedis

Product Details

ModelMultifiltrate
BrandFRESENIUS
CategoryStationary dialysis machines
Posted13.02.2026
Views322

Used - Good FRESENIUS Multifiltrate


Condition:: Used - Good
Warranty (month):: 3
Year:: 2010
Availability:: In stock
Shipping from:: Poland
Sales area:: Afghanistan, Albania, Algeria


Seller:

trustproapproved

Poland

Description

This price is negotiable

Year of production: 2010

Model: MultiFiltrate

Software: 5.4 es

German manufacture

The combination of optimally coordinated treatment programmes and solutions makes multiFiltrate a truly multi-purpose tool for a wide range of applications.

Power supply: 220/230 V, 50 Hz

Therapy range:

CVVH – in continuous venous haemofiltration, the filtrate is removed from the blood by convection using Ultraflux AV filters

Pre-Post CVVH – significantly higher convective volume exchange, up to 9.6 litres/hour, is achieved thanks to the high volume of Pre-Post CVVH. The replacement of the haemofiltration solution takes place simultaneously in pre- and post-dilution

CVVHD – ensures effective diffusional elimination of small and medium-sized molecules, even at low blood flow rates (e.g. 100–120 ml/min)

CVVHD EMiC2 – the inclusion of Ultraflux EMiC 2 in CVVHD therapy increases the average molecular clearance (e.g. β2-microglobulin, interleukin 6, myoglobin) and may even exceed the efficiency of CVVH

Ci-Ca CVVHD – integrated, regional citrate anticoagulation. Citrate binds calcium ions and inhibits many stages of the coagulation cascade. This results in effective anticoagulation and long filter patency. In addition, the patient's acid-base status can be selectively controlled

Ci-Ca CVVHD EMiC2 – therapy combining the advantages of CVVHD and citrate anticoagulation with improved removal of intermediate molecules

CVVHDF – CVVHDF treatment combines the advantages of diffusive and convective elimination of toxic substances, offering effective elimination of low- and medium-molecular-weight compounds. Substitution can take place before or after dilution

MPS – the patient's plasma is separated by a membrane filter and replaced, for example, with donor plasma

HP – haemoperfusion is used for the adsorption elimination of toxic substances from the blood using a whole blood adsorber

multiFiltrate ped CRRT – for the treatment of infants and young children. Continuous renal replacement therapy can be performed in CVVH mode (before or after dilution) and CVVHD

multiFiltrate SCUF – slow, continuous ultrafiltration provides gentle drainage through slow removal of ultrafiltrate. The Ultraflux haemofiltration filter is connected to reduced-volume tubing to achieve very low ultrafiltration rates

MultiFiltrate Ci-Ca includes:

6 roller tube pumps

2 integrated solution heating systems

1 integrated heparin pump

1 robust and highly accurate weighing system

The price does not include start-up and configuration of the device. Before use, please contact Fresenius Medical Care service to prepare the device for operation.

Didn’t find what you were looking for? Place your own ad on the Bimedis platform

Place your advert on Bimedis and reach buyers worldwide.

SELL

Related searches